Comparison...
Prima Biomed
One candidate /higher risk of failure
Cvac in a Phase 2/b Trial, no results
Cvac in a Phase 2/3 Pivotal Trial, first enrolments just commenced.
$45 million cash at bank
Market opportunity for Cvac $3.6 billion +
Prima Biomed Market Cap $224 million
Neuren Pharmaceuticals
Multiple Candidates/reduced risk of failure
Multiple Trials/FDA approval for Phase2 NNZ2566 oral in progress.
$9 million cash at bank and TBI Trial funded by US army
Market opportunity for motiva/NNZ2566 $2-$4 Billion +
Neuren Pharmaceuticals Market cap $31 Million lol
Go Figure
- Forums
- ASX - By Stock
- NEU
- exciting old link for new onlookers
exciting old link for new onlookers, page-2
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B |
Open | High | Low | Value | Volume |
$14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $13.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.07 | 6644 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.990 |
1 | 300 | 13.970 |
1 | 1432 | 13.950 |
2 | 1230 | 13.900 |
1 | 720 | 13.890 |
Price($) | Vol. | No. |
---|---|---|
14.420 | 175 | 1 |
14.500 | 2985 | 2 |
14.800 | 2850 | 2 |
14.860 | 500 | 1 |
14.960 | 445 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |